Development

Lilly reports weight loss from an amylin combination

development2026-10-03biotech

Claim

The newsletter reports a Lilly amylin combination delivering 23.3% weight loss.

Reported metric: 23.3%

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Indexed from Dr. Alex Wissner-Gross’s October 3, 2026 newsletter. Linked-source claims have not been independently verified.

Knowledge graphopen in browser →

Reported in
Actor
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.